Nova Eye Medical Ltd (EYE)

Currency in AUD
0.145
-0.005(-3.33%)
Delayed Data·
EYE Scorecard
Full Analysis
Quickly burning through cash
Earnings results expected in 8 days
EYE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.1450.150
52 wk Range
0.0860.250
Key Statistics
Bid/Ask
0.14 / 0.145
Prev. Close
0.15
Open
0.148
Day's Range
0.145-0.15
52 wk Range
0.086-0.25
Volume
545.71K
Average Volume (3m)
491.26K
1-Year Change
-40.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EYE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.373
Upside
+157.47%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Nova Eye Medical Ltd Company Profile

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter which offers malleability and manoeuvrability than common nylon alternatives; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Compare EYE to Peers and Sector

Metrics to compare
EYE
Peers
Sector
Relationship
P/E Ratio
−5.0x−4.4x−0.6x
PEG Ratio
−0.10−0.060.00
Price/Book
2.5x2.7x2.6x
Price / LTM Sales
1.6x3.0x3.3x
Upside (Analyst Target)
140.0%51.4%39.1%
Fair Value Upside
Unlock10.0%4.5%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.373
(+157.47% Upside)

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
7.33M / --
EPS Revisions
Last 90 days

EYE Income Statement

FAQ

What Stock Exchange Does Nova Eye Medical Trade On?

Nova Eye Medical is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Nova Eye Medical?

The stock symbol for Nova Eye Medical is "EYE."

What Is the Nova Eye Medical Market Cap?

As of today, Nova Eye Medical market cap is 41.25M.

What Is Nova Eye Medical's Earnings Per Share (TTM)?

The Nova Eye Medical EPS (TTM) is -0.04.

When Is the Next Nova Eye Medical Earnings Date?

Nova Eye Medical will release its next earnings report on 26 Aug 2025.

From a Technical Analysis Perspective, Is EYE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Nova Eye Medical Stock Split?

Nova Eye Medical has split 1 times.

How Many Employees Does Nova Eye Medical Have?

Nova Eye Medical has 301 employees.

What is the current trading status of Nova Eye Medical (EYE)?

As of 19 Aug 2025, Nova Eye Medical (EYE) is trading at a price of 0.15, with a previous close of 0.15. The stock has fluctuated within a day range of 0.15 to 0.15, while its 52-week range spans from 0.09 to 0.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.